Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Alessandro D. Santin, MD
CONTACT
Lisa Baker, RN
CONTACT
Lead
Yale University
With
This is an open-label, Phase 2 study designed to assess the clinical activity of sacituzumab govitecan in subjects with recurrent or persistent cervical cancer.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted